Biosimilar bevacizumab on the PBS - information for health professionals and patients
Page last updated: 21 May 2021
A biosimilar brand of bevacizumab (Mvasi®) will be listed on the PBS on 1 June 2021. Information about this listing, and about biosimilars, can be found on the Biosimilar Awareness Initiative web page. From 1 June 2021 Avastin® will no longer be available on the PBS, and Mvasi® will be the sole brand of bevacizumab available on the PBS.